Lipoblastoma: Understanding Your Pathology Report

Section Editor: Anthea Girdwood MD FRCPC
October 22, 2026

Lipoblastoma is a noncancerous tumor made of young fat cells. It is almost always found in babies and young children, and most are under 3 years old when it is diagnosed. Parents usually notice a soft, painless lump under the skin of an arm, a leg, or the trunk. The lump can grow quickly, which is often what brings a child to the doctor.

Lipoblastoma does not spread to other parts of the body, and surgery to remove it is usually all the treatment a child needs. The name can sound alarming because it resembles liposarcoma, a fat cell cancer, but the two are different diseases. This article explains what lipoblastoma is, how a pathologist confirms the diagnosis, and what the terms in your child’s pathology report mean.

Who gets lipoblastoma?

Lipoblastoma is a tumor of infancy and early childhood, and between 75% and 90% of cases are found before age 3. It is uncommon in older children and very rare in adults, and boys are affected more often than girls.

Most lipoblastomas start in the subcutaneous tissue, the layer of fat just under the skin. The arms, legs, and trunk are the most common locations. Less often, lipoblastoma develops deeper in the body, for example, in the neck, chest, abdomen, or the area behind the abdominal organs.

What causes lipoblastoma?

Most lipoblastomas result from a change in a gene called PLAG1, located on chromosome 8. In tumor cells, PLAG1 joins part of another gene. This joining, called a rearrangement, switches PLAG1 on in cells where it would normally be quiet. The PLAG1 protein then drives young fat cells to keep growing.

Researchers find a PLAG1 rearrangement in roughly 60% to 70% of lipoblastomas when the tumor is tested. A smaller number carry a change in a related gene called HMGA2, or an extra copy of chromosome 8. These changes are found only in the tumor cells and are not inherited, and lipoblastoma is not linked to any known family cancer syndrome.

What are the symptoms of lipoblastoma?

The most common sign of lipoblastoma is a soft, painless lump that grows over weeks or months. Most tumors measure 2 to 5 cm across when removed, though some grow larger than 10 cm.

A lipoblastoma deep in the body may not be visible from the outside. Depending on its location, a large deep tumor can press on nearby structures. For example, in the neck or chest, it may cause noisy breathing or difficulty swallowing.

How is the diagnosis of lipoblastoma made?

A pathologist diagnoses lipoblastoma by examining tissue from the lump under a microscope. Before surgery, an ultrasound or MRI usually shows the lump is mostly fat. Imaging cannot always tell lipoblastoma apart from other fatty tumors, so tissue is needed to confirm the diagnosis.

For a small lump under the skin, the surgeon often removes the whole tumor in one operation, called an excision. That single specimen provides both diagnosis and treatment. For a large or deep tumor, a small sample may first be taken with a needle, called a biopsy, to plan surgery.

Under the microscope, the pathologist looks for a tumor made of fat cells at different stages of development. Some of these are lipoblasts, which are young fat cells. The pathologist also confirms that the cells look orderly and lack cancer features. When the appearance is not clear-cut, special stains and genetic tests, described below, help confirm the diagnosis.

What does lipoblastoma look like under the microscope?

Under the microscope, lipoblastoma is made of rounded groups of fat cells called lobules. Thin bands of fibrous tissue separate the lobules from one another. This lobular pattern is one of the most helpful clues to the diagnosis.

Within each lobule, the fat cells range from very immature to fully mature, and the most immature cells are called lipoblasts. These cells contain small fat droplets that press against the nucleus, giving it a scalloped outline. Mature fat cells, like those in normal adipose tissue, are often found in the center of the lobules.

The space between the cells is often myxoid, meaning it looks loose, pale, and jelly-like, with fine, branching blood vessels running through it. The cells lack the nuclear atypia seen in cancer, and dividing cells are rare.

The amount of mature fat in lipoblastoma tends to increase as a child gets older. In some older children, the tumor looks almost entirely like ordinary mature fat. Pathologists sometimes describe this as a lipoma-like pattern, because it can closely resemble a lipoma.

What are the different types of lipoblastoma?

The WHO Classification of Soft Tissue and Bone Tumors (5th edition, 2020) groups lipoblastoma and lipoblastomatosis together as one noncancerous fat cell tumor. The two names describe the same disease growing in two different ways, and your child’s pathology report may use either term.

Lipoblastoma (localized type). This is the more common form, in which the tumor is a single, well-defined lump, often surrounded by a thin capsule. It usually sits just under the skin and can often be removed completely.
Lipoblastomatosis (diffuse type). This form grows deeper, often into muscle, and has no clear border, a pattern pathologists describe as infiltrative. Because it spreads between normal tissues, it is harder to remove completely and is more likely to come back.

Both types look the same under the microscope, carry the same genetic changes, and neither spreads to other parts of the body.

Immunohistochemistry

Immunohistochemistry is a test that uses stains to show which proteins are present in cells. In lipoblastoma, it helps the pathologist confirm that the tumor is made of fat cells and rule out other tumors that can look similar. Your child’s report may list some of the following results.

PLAG1. Lipoblastoma cells often show strong staining for PLAG1 in the nucleus. A positive result supports the diagnosis because PLAG1 is switched on in most lipoblastomas. A negative result does not rule out lipoblastoma, since some tumors use a different genetic change.
S100. This protein is found in fat cells, so a positive result in lipoblastoma confirms that the tumor is made of fat cells.
CD34. This protein is found in some young connective tissue cells and in blood vessels, and it is usually positive in lipoblastoma.
Desmin. Some less mature lipoblastoma cells are positive for desmin. This result is expected and does not suggest a muscle tumor.
MDM2 and CDK4. These proteins are usually negative in lipoblastoma, and a negative result helps rule out some adult-onset liposarcomas.

Not every child’s tumor needs every stain, and many lipoblastomas can be diagnosed on their microscopic appearance alone. The pathologist chooses stains based on what the tissue shows.

How is lipoblastoma told apart from liposarcoma?

Lipoblastoma and liposarcoma can look alike under the microscope, because both contain lipoblasts and can have a myxoid background. This is why the word liposarcoma sometimes appears in a lipoblastoma report, usually in a sentence explaining why it was excluded.

The tumor most likely to confuse is myxoid liposarcoma, a cancer. Myxoid liposarcoma is very rare in young children and occurs mostly in teenagers and adults, so the child’s age is an important clue. Lipoblastoma also has the lobules and mature fat described above, while myxoid liposarcoma usually does not.

When the appearance is not clear-cut, genetic tests settle the question. The most common is fluorescence in situ hybridization (FISH), which uses glowing probes to show whether a gene has broken apart. Your child’s report may describe one or both of these results:

PLAG1 rearrangement detected. This result confirms lipoblastoma, and the report may describe it as positive for a PLAG1 rearrangement or as PLAG1 break-apart positive.
PLAG1 rearrangement not detected. This result does not rule out lipoblastoma because some tumors have a different genetic change. The diagnosis then rests on the microscopic appearance and the other test results.
DDIT3 rearrangement not detected. This is suspected to be lipoblastoma, and it rules out myxoid liposarcoma, which almost always carries a DDIT3 rearrangement.
DDIT3 rearrangement detected. This result supports myxoid liposarcoma rather than lipoblastoma and is not expected in a lipoblastoma.

Some laboratories test for these changes with next-generation sequencing (NGS) instead of FISH. NGS can identify the exact gene joined to PLAG1, which the report may list by name. The partner gene does not change how lipoblastoma behaves.

A small biopsy can occasionally be hard to classify because it shows only part of the tumor. In older children, a lipoma-like lipoblastoma can also be mistaken for an ordinary lipoma. When the surgeon removes the entire tumor, the pathologist examines it all, and the final diagnosis is based on that specimen.

Surgical margins

When the surgeon removes a lipoblastoma, the pathologist examines the cut edges of the tissue, called the margins. Margin status is the most important finding on a lipoblastoma report for predicting whether the tumor will come back. Your child’s report may describe the margins in one of these ways:

Negative margin. No tumor cells are seen at the cut edge, which suggests the lipoblastoma was completely removed. Some reports also give the distance between the tumor and the nearest margin.
Positive margin. Tumor cells are seen at the cut edge, meaning some lipoblastoma may remain in the body, which raises the chance it will grow back.

A positive margin is more common with lipoblastomatosis because the tumor grows between normal tissues without a clear border. Surgeons also try to protect nearby nerves, muscles, and blood vessels in a growing child. For this reason, a positive margin may reflect a deliberate choice rather than an incomplete operation.

Can lipoblastoma come back?

Lipoblastoma is a noncancerous tumor, and it does not spread to lymph nodes or other organs. Lipoblastoma is not known to turn into a cancer, and most children are cured by surgery.

Lipoblastoma can recur in the same place after surgery. Published studies report recurrence rates of 13% to 46% in children. The rate varies widely because studies differ in how many children had lipoblastomatosis or how complete the removal was.

The main factors linked to recurrence are:

Positive margins. Tumor left behind at the cut edge is the strongest predictor of recurrence.
Lipoblastomatosis. The diffuse type is harder to remove completely and recurs more often than the localized type.
Deep location. Tumors in the neck, chest, or abdomen can be harder to remove completely than tumors just under the skin.

Recurrence has been reported as late as six years after surgery. A recurrent lipoblastoma is still a noncancerous tumor, and it still does not spread to other parts of the body.

What happens after a diagnosis of lipoblastoma?

Once a pathologist confirms lipoblastoma, the next steps depend mostly on the margins and whether the tumor is localized or diffuse; a pediatric surgeon usually leads care, and lipoblastoma usually does not need chemotherapy or radiation.

Negative margins, localized lipoblastoma. Surgery is usually the only treatment needed, and the care team will usually arrange follow-up visits to check the area.
Positive margins or lipoblastomatosis. The care team weighs the chance of regrowth against the risk of a second operation near important structures. Depending on the situation, the team may consider closer follow-up or further surgery.
Recurrence. If lipoblastoma recurs, the care team will consider whether to remove it. The decision depends on its size, location, and any symptoms it causes.

Because recurrence can appear years later, follow-up for lipoblastoma often continues for several years. This may include physical examinations and, for deeper tumors, imaging such as ultrasound or MRI. Your child’s care team can explain how long follow-up will last and what it will involve.

Questions to ask your doctor

Was my child’s tumor the localized type, lipoblastoma, or the diffuse type, lipoblastomatosis?
Was the whole tumor removed, or was this a biopsy?
Were the margins negative or positive?
If a margin was positive, will my child need more surgery, or will the area be watched?
Was a PLAG1 test done, and what did it show?
Was a DDIT3 test done to rule out myxoid liposarcoma?
Why does my child’s report mention liposarcoma?
How large was the tumor, and was it pressing on anything nearby?
How often will my child need follow-up visits, and for how many years?
Will my child need ultrasound or MRI scans during follow-up?
What changes should I watch for at home that could mean the tumor has come back?
Does this diagnosis have any meaning for my other children?